Novartis (NVS) News Today $126.94 +0.12 (+0.10%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$127.34 +0.40 (+0.32%) As of 08/22/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Novartis AG $NVS Shares Bought by Charles Schwab Investment Management Inc.August 24 at 3:18 AM | marketbeat.comRep. Lisa C. McClain Purchases Shares of Novartis AG (NYSE:NVS)August 24 at 2:38 AM | americanbankingnews.comNovartis AG $NVS Stock Position Raised by Martin Investment Management LLCAugust 23 at 7:59 AM | marketbeat.comNorthern Trust Corp Purchases 47,690 Shares of Novartis AG $NVSAugust 23 at 5:24 AM | marketbeat.comNovartis AG $NVS Shares Sold by American Century Companies Inc.August 23 at 4:43 AM | marketbeat.comInvesco Ltd. Lowers Stock Holdings in Novartis AG $NVSAugust 23 at 4:16 AM | marketbeat.comNovartis AG $NVS Position Increased by Osterweis Capital Management Inc.August 22 at 7:13 AM | marketbeat.comKepler Capital Reaffirms Their Buy Rating on Novartis AG (NOVN)August 22 at 6:36 AM | theglobeandmail.comNovartis price target raised to CHF 120 from CHF 115 at Deutsche BankAugust 22 at 6:36 AM | msn.comNovartis AG $NVS Holdings Decreased by Wellington Management Group LLPAugust 22 at 5:05 AM | marketbeat.comNovartis (NYSE:NVS) Sets New 1-Year High - Time to Buy?August 21 at 11:43 AM | marketbeat.comNovartis AG $NVS Shares Bought by Brooklyn Investment GroupAugust 21 at 4:59 AM | marketbeat.comRaymond James Financial Inc. Sells 11,448 Shares of Novartis AG $NVSAugust 21 at 4:42 AM | marketbeat.comNovartis AG $NVS Stock Position Reduced by Cambiar Investors LLCAugust 20, 2025 | marketbeat.comCorient IA LLC Buys Shares of 5,000 Novartis AG (NYSE:NVS)August 19, 2025 | marketbeat.comCresset Asset Management LLC Has $13.13 Million Stake in Novartis AG (NYSE:NVS)August 19, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Purchased by Kovitz Investment Group Partners LLCAugust 19, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by Boston PartnersAugust 19, 2025 | marketbeat.comEthic Inc. Trims Position in Novartis AG (NYSE:NVS)August 18, 2025 | marketbeat.comVirtu Financial LLC Decreases Position in Novartis AG (NYSE:NVS)August 18, 2025 | marketbeat.comBenjamin Edwards Inc. Sells 32,839 Shares of Novartis AG (NYSE:NVS)August 18, 2025 | marketbeat.comDeutsche Bank AG Raises Holdings in Novartis AG (NYSE:NVS)August 18, 2025 | marketbeat.comNew Novartis ESC data highlights strength of cardiovascular portfolioAugust 18, 2025 | globenewswire.comMassive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the StormAugust 17, 2025 | fool.comRep. Lisa C. McClain Sells Novartis AG (NYSE:NVS) SharesAugust 17, 2025 | marketbeat.comDimensional Fund Advisors LP Purchases 422,869 Shares of Novartis AG (NYSE:NVS)August 17, 2025 | marketbeat.comNeuberger Berman Group LLC Sells 3,737 Shares of Novartis AG (NYSE:NVS)August 17, 2025 | marketbeat.comFox Run Management L.L.C. Purchases 3,351 Shares of Novartis AG (NYSE:NVS)August 16, 2025 | marketbeat.comCookson Peirce & Co. Inc. Takes $24.76 Million Position in Novartis AG (NYSE:NVS)August 16, 2025 | marketbeat.comHighTower Advisors LLC Has $26.52 Million Position in Novartis AG (NYSE:NVS)August 16, 2025 | marketbeat.com2 Dividend Stocks to Buy and HoldAugust 15, 2025 | msn.comNational Bank of Canada FI Reduces Stake in Novartis AG (NYSE:NVS)August 15, 2025 | marketbeat.comMondrian Investment Partners LTD Lowers Position in Novartis AG (NYSE:NVS)August 14, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Purchased by Citigroup Inc.August 14, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by Callan Family Office LLCAugust 13, 2025 | marketbeat.comFrank Rimerman Advisors LLC Purchases Shares of 2,711 Novartis AG (NYSE:NVS)August 13, 2025 | marketbeat.comXTX Topco Ltd Sells 8,098 Shares of Novartis AG (NYSE:NVS)August 13, 2025 | marketbeat.comNovartis ianalumab Phase III trial meets primary endpoint in ITPAugust 12, 2025 | msn.comTodd Asset Management LLC Purchases 5,329 Shares of Novartis AG (NYSE:NVS)August 12, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.August 12, 2025 | marketbeat.comNovartis shares slightly up after Ianalumab meets goals in Phase 3 trialAugust 12, 2025 | finance.yahoo.comNovartis shares edge higher after ianalumab hits key goals in Phase 3 trialAugust 12, 2025 | msn.comNovartis AG: Balancing Promising Drug Developments with Market Challenges – Hold RecommendationAugust 12, 2025 | tipranks.comNovartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failureAugust 12, 2025 | globenewswire.comNovartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As WellAugust 11, 2025 | msn.comAlphaCore Capital LLC Purchases New Stake in Novartis AG (NYSE:NVS)August 11, 2025 | marketbeat.comNovartis (NYSE:NVS) HeadlineAugust 11, 2025 | gurufocus.comNovartis's Ianalumab Meets Key Goal in Late-Stage Trials for Autoimmune DiseaseAugust 11, 2025 | wsj.comNovartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren's diseaseAugust 11, 2025 | prnewswire.comNovartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren's diseaseAugust 11, 2025 | globenewswire.com Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address NVS Media Mentions By Week NVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼1.340.69▲Average Medical News Sentiment NVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼2521▲NVS Articles Average Week Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZN News NVO News SNY News GSK News TAK News ARGX News ONC News BNTX News INSM News TEVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access